1sdf: Difference between revisions

No edit summary
No edit summary
Line 4: Line 4:


==Overview==
==Overview==
The three-dimensional structure of stromal cell-derived factor-1 (SDF-1), was determined by NMR spectroscopy. SDF-1 is a monomer with a disordered, N-terminal region (residues 1-8), and differs from other chemokines in the, packing of the hydrophobic core and surface charge distribution. Results, with analogs showed that the N-terminal eight residues formed an important, receptor binding site; however, only Lys-1 and Pro-2 were directly, involved in receptor activation. Modification to Lys-1 and/or Pro-2, resulted in loss of activity, but generated potent SDF-1 antagonists., Residues 12-17 of the loop region, which we term the RFFESH motif, unlike, the N-terminal region, were well defined in the SDF-1 structure. The, RFFESH formed a receptor binding site, which we propose to be an important, initial docking site of SDF-1 with its receptor. The ability of the SDF-1, analogs to block HIV-1 entry via CXCR4, which is a HIV-1 coreceptor for, the virus in addition to being the receptor for SDF-1, correlated with, their affinity for CXCR4. Activation of the receptor is not required for, HIV-1 inhibition.
The three-dimensional structure of stromal cell-derived factor-1 (SDF-1) was determined by NMR spectroscopy. SDF-1 is a monomer with a disordered N-terminal region (residues 1-8), and differs from other chemokines in the packing of the hydrophobic core and surface charge distribution. Results with analogs showed that the N-terminal eight residues formed an important receptor binding site; however, only Lys-1 and Pro-2 were directly involved in receptor activation. Modification to Lys-1 and/or Pro-2 resulted in loss of activity, but generated potent SDF-1 antagonists. Residues 12-17 of the loop region, which we term the RFFESH motif, unlike the N-terminal region, were well defined in the SDF-1 structure. The RFFESH formed a receptor binding site, which we propose to be an important initial docking site of SDF-1 with its receptor. The ability of the SDF-1 analogs to block HIV-1 entry via CXCR4, which is a HIV-1 coreceptor for the virus in addition to being the receptor for SDF-1, correlated with their affinity for CXCR4. Activation of the receptor is not required for HIV-1 inhibition.


==Disease==
==Disease==
Line 17: Line 17:
[[Category: Single protein]]
[[Category: Single protein]]
[[Category: Clark-Lewis, I.]]
[[Category: Clark-Lewis, I.]]
[[Category: Crump, M.P.]]
[[Category: Crump, M P.]]
[[Category: Rajarathnam, K.]]
[[Category: Rajarathnam, K.]]
[[Category: Sykes, B.D.]]
[[Category: Sykes, B D.]]
[[Category: chemokines]]
[[Category: chemokines]]
[[Category: cytokine]]
[[Category: cytokine]]
Line 26: Line 26:
[[Category: stromal cell-derived factor-1/g-coupled receptors]]
[[Category: stromal cell-derived factor-1/g-coupled receptors]]


''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri Feb 15 16:53:23 2008''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 15:00:22 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA